Valeant Pharmaceuticals (Dermatology products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Valeant Pharmaceuticals (Dermatology products) General Information

Description

A portfolio of dermatology products. The dermatology products are primarily utilized for skin care treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2150 St. Elzéar Boulevard West
  • Laval, Quebec H7L 4A8
  • Canada
Primary Industry
Buildings and Property
Other Industries
Personal Products
Acquirer
Nestlé
Corporate Office
  • 2150 St. Elzéar Boulevard West
  • Laval, Quebec H7L 4A8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valeant Pharmaceuticals (Dermatology products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Valeant Pharmaceuticals (Dermatology products)‘s full profile, request access.

Request a free trial

Valeant Pharmaceuticals (Dermatology products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Valeant Pharmaceuticals (Dermatology products)‘s full profile, request access.

Request a free trial

Valeant Pharmaceuticals (Dermatology products) FAQs

  • Where is Valeant Pharmaceuticals (Dermatology products) headquartered?

    Valeant Pharmaceuticals (Dermatology products) is headquartered in Laval, Canada.

  • What industry is Valeant Pharmaceuticals (Dermatology products) in?

    Valeant Pharmaceuticals (Dermatology products)’s primary industry is Buildings and Property.

  • Is Valeant Pharmaceuticals (Dermatology products) a private or public company?

    Valeant Pharmaceuticals (Dermatology products) is a Private company.

  • What is the current valuation of Valeant Pharmaceuticals (Dermatology products)?

    The current valuation of Valeant Pharmaceuticals (Dermatology products) is .

  • What is Valeant Pharmaceuticals (Dermatology products)’s current revenue?

    The current revenue for Valeant Pharmaceuticals (Dermatology products) is .

  • Who are Valeant Pharmaceuticals (Dermatology products)’s investors?

    Bausch Health Companies has invested in Valeant Pharmaceuticals (Dermatology products).

  • When was Valeant Pharmaceuticals (Dermatology products) acquired?

    Valeant Pharmaceuticals (Dermatology products) was acquired on 10-Jul-2014.

  • Who acquired Valeant Pharmaceuticals (Dermatology products)?

    Valeant Pharmaceuticals (Dermatology products) was acquired by Nestlé.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »